An important example is the discovery of epidermal growth factor receptor gene (EGFR) alterations, and the successful administration of EGFR tyrosine kinase inhibitors (TKIs) in lung cancer patients whose tumor harbors EGFR alterations [5,10,13]. The gene discussed is EGFR; the disease is neoplasm.